GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sonic Healthcare Ltd (FRA:SAB) » Definitions » Debt-to-EBITDA

Sonic Healthcare (FRA:SAB) Debt-to-EBITDA : 2.48 (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Sonic Healthcare Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sonic Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €408 Mil. Sonic Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €2,378 Mil. Sonic Healthcare's annualized EBITDA for the quarter that ended in Jun. 2024 was €1,123 Mil. Sonic Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 was 2.48.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sonic Healthcare's Debt-to-EBITDA or its related term are showing as below:

FRA:SAB' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.08   Med: 2.86   Max: 3.3
Current: 2.72

During the past 13 years, the highest Debt-to-EBITDA Ratio of Sonic Healthcare was 3.30. The lowest was 1.08. And the median was 2.86.

FRA:SAB's Debt-to-EBITDA is ranked worse than
65.42% of 107 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.8 vs FRA:SAB: 2.72

Sonic Healthcare Debt-to-EBITDA Historical Data

The historical data trend for Sonic Healthcare's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonic Healthcare Debt-to-EBITDA Chart

Sonic Healthcare Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.26 1.26 1.08 1.80 2.72

Sonic Healthcare Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 1.64 1.95 2.66 2.48

Competitive Comparison of Sonic Healthcare's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Sonic Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonic Healthcare's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sonic Healthcare's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sonic Healthcare's Debt-to-EBITDA falls into.



Sonic Healthcare Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sonic Healthcare's Debt-to-EBITDA for the fiscal year that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(407.767 + 2377.61) / 1023.567
=2.72

Sonic Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(407.767 + 2377.61) / 1122.92
=2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2024) EBITDA data.


Sonic Healthcare  (FRA:SAB) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sonic Healthcare Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sonic Healthcare's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonic Healthcare Business Description

Traded in Other Exchanges
Address
225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.

Sonic Healthcare Headlines

No Headlines